Schizophrenia and risk of dementia: a meta-analysis study
Open accessThe DOI matches its Crossref record; 9 of the 9 references it cites were found in a registry or an index.
Abstract
BACKGROUND: Evidence suggests that schizophrenia may be associated with an increased risk of dementia, but results from prior studies have been inconsistent. This study aimed to estimate the relationship between schizophrenia and incident dementia using a quantitative meta-analysis. METHODS: Several databases were used to gather relevant information, including PubMed, Embase, and Web of Science, with the publication date of articles limited up to December 23, 2017. All studies reported a multivariate-adjusted estimate, represented as relative risk (RR) with 95% confidence intervals (CIs), for the association between schizophrenia and risk of dementia incidence. Pooled RRs were calculated using a random-effects model. RESULTS: Six studies met our inclusion criteria for this meta-analysis, which included 206,694 cases of dementia and 5,063,316 participants. All individuals were without dementia at baseline. Overall, the quantitative meta-analysis suggested that subjects with schizophrenia were associated with a significantly greater risk of dementia incidence (RR 2.29; 95% CI 1.35-3.88) than those without. CONCLUSION: The results of this meta-analysis indicate that individuals with schizophrenia may have an increased risk for the development of dementia. Future studies should explore whether schizophrenia is a modifiable risk factor for dementia.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Stang, A. (2010) · European Journal of Epidemiology · doi:10.1007/s10654-010-9491-z · Cited by 17,396
Preferred reporting items for systematic reviews and meta-analyses: The PRISMA statement
Moher, D., Liberati, A., Tetzlaff, J., & Altman, D. G. (2010) · International Journal of Surgery · doi:10.1016/j.ijsu.2010.02.007 · Cited by 12,156
The global prevalence of dementia: a systematic review and metaanalysis.
Prince, M., Bryce, R., Albanese, E., Wimo, A., Ribeiro, W., & Ferri, C. P. (2013) · Alzheimer's & Dementia · doi:10.1016/j.jalz.2012.11.007 · Cited by 4,941 · cited 1×
“Based on a shifting demographic and associated epidemiological profile worldwide, the number of people affected is predicted to double every 20 years and is creating a substantial financial, social, and public health burden, particularly in resource-poor countries.(4,5) Schizophrenia is a brain disorder with symptoms…”
Sex modifies the APOE ‐related risk of developing Alzheimer disease
Altmann, A., Tian, L., Henderson, V. W., Greicius, M. D., & Alzheimer's Disease Neuroimaging Initiative Investigators (2014) · Annals of Neurology · doi:10.1002/ana.24135 · Cited by 891
Absolute Risk of Suicide After First Hospital Contact in Mental Disorder
Nordentoft, M. (2011) · Archives of General Psychiatry · doi:10.1001/archgenpsychiatry.2011.113 · Cited by 689 · cited 1×
“First, schizophrenia patients could be a proxy variable for several chronic conditions, including cerebrovascular disease, 63 substance abuse, 64 atrial fibrillation or flutter, 65,66 peripheral vascular disease, 63,67 diabetes mellitus, 68 ischemic heart disease, 63,67,69 and congestive heart…”
Laursen, T. M., Munk-Olsen, T., Agerbo, E., Gasse, C., & Mortensen, P. B. (2009) · Archives of General Psychiatry · doi:10.1001/archgenpsychiatry.2009.61 · Cited by 271 · cited 1×
“…conditions, including cerebrovascular disease, 63 substance abuse, 64 atrial fibrillation or flutter, 65,66 peripheral vascular disease, 63,67 diabetes mellitus, 68 ischemic heart disease, 63,67,69 and congestive heart failure, 63,65 all of which are well-established risk factors for dementia.”
Rusanen, M., Kivipelto, M., Levälahti, E., Laatikainen, T., Tuomilehto, J., Soininen, H., & Ngandu, T. (2014) · Journal of Alzheimer's Disease · doi:10.3233/jad-132363 · Cited by 177 · cited 2×
“…conditions, including cerebrovascular disease, 63 substance abuse, 64 atrial fibrillation or flutter, 65,66 peripheral vascular disease, 63,67 diabetes mellitus, 68 ischemic heart disease, 63,67,69 and congestive heart failure, 63,65 all of which are well-established risk factors for dementia.”
Viertiö, S., Tuulio-Henriksson, A., Perälä, J., Saarni, S. I., Koskinen, S., Sihvonen, M., Lönnqvist, J., & Suvisaari, J. (2012) · European Psychiatry · doi:10.1016/j.eurpsy.2010.12.005 · Cited by 58 · cited 1×
“Social disability and substantial functional impairment are common results of these disturbances.(9) Diminished cognition is a basic feature of schizophrenia.”
Comparing neurocognition in severe chronic schizophrenia and frontotemporal dementia
Chan, H.-M., Stolwyk, R., Kelso, W., Neath, J., Walterfang, M., Mocellin, R., Pavlis, A., & Velakoulis, D. (2014) · Australian & New Zealand Journal of Psychiatry · doi:10.1177/0004867414529477 · Cited by 11
Cited by
Shared mechanisms across the major psychiatric and neurodegenerative diseases
Wingo, T. S., Liu, Y., Gerasimov, E. S., Vattathil, S. M., Wynne, M. E., Liu, J., Lori, A., Faundez, V., Bennett, D. A., Seyfried, N. T., et al. (2022) · Nature Communications · doi:10.1038/s41467-022-31873-5 · Cited by 190
Stafford, J., Chung, W. T., Sommerlad, A., Kirkbride, J. B., & Howard, R. (2022) · International Journal of Geriatric Psychiatry · doi:10.1002/gps.5711 · Cited by 126
Age-Specific Prevalence and Incidence of Dementia Diagnoses Among Older US Adults With Schizophrenia
Stroup, T. S., Olfson, M., Huang, C., Wall, M. M., Goldberg, T., Devanand, D. P., & Gerhard, T. (2021) · JAMA Psychiatry · doi:10.1001/jamapsychiatry.2021.0042 · Cited by 112
Hong, B., Bea, S., Ko, H. Y., Kim, W. J., Cho, Y. M., & Shin, J.-Y. (2024) · Annals of Internal Medicine · doi:10.7326/m23-3220 · Cited by 33
Cortes-Flores, H., Torrandell-Haro, G., & Brinton, R. D. (2024) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2024.1358568 · Cited by 12
Metadata
- Authors
- Cai, L., & Huang, J.
- Venue
- Neuropsychiatric Disease and Treatment
- Publisher
- Informa UK Limited
- Published
- 2018-08
- Volume
- Volume 14
- Pages
- 2047-2055
- ISSN
- 1176-6328 (ISSN-L)
- 1178-2021
- OpenAlex
- W2887701645
- Cited by
- 141
- References
- 9
- FWCI
- 1.82
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.